ABSTRACT-Effect of an intraperitoneal injection of cimetidine at a daily dose of 160 mg/kg for two weeks on biliary lipid secretion, fecal excretion of bile acids and intestinal bile acids was studied in rats. Bile flow, biliary lipid secretion and fecal excretion of bile acids remained unchanged, while the pool size of bile acids decreased by cimetidine treatment. Chenodeoxycholic acid increased with a concomitant decrease of 8-muricholic acid in the biliary bile acid composition of cimetidine-treated rats.
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Cimetidine, a histamine H2-receptor antagonist, is widely used to treat peptic ulcers. There have been some reports suggesting that H2-receptor antagonists, including cimetidine, reduce splanchnic blood flow (1-3), which could cause the alteration in enterohepatic circulation of bile acids, especially in the reabsorption of bile acids in the intestine. On the other hand, cimetidine is reported to impair cytochrome P-450-mediated drug metabolism because of its interaction with microsomal P-450 (4). Cholesterol and bile acids are catalyzed by some microsomal cytochrome P-450 species including cholesterol 7a-hydroxylase, 7 a -hydroxy-4-cholesten-3-one 12 a -hydroxylase, taurodeoxycholate 7a-hydroxylase and taurochenodeoxycholate 6,Q-hydroxylase (5). Accordingly, one can expect that cimetidine has some effects on bile acid metabolism by altering the enterohepatic circulation of bile acids and by inhibiting the hepatic microsomal cytochrome P-450 species. However, studies on the effects of cimetidine on biliary lipid secretion and bile acid metabolism are very few and the results obtained are controversial (6) (7) (8) .
In this study, we examined the effect of a high dose of cimetidine on biliary lipid secretion, fecal excretion of bile acids and intestinal bile acids in rats.
Wistar strain male rats weighing about 250 g were used. They were maintained in an airconditioned room (25 ± 1°C, 50-60% humidity) lighted 12 hr a day (8 A.M. to 8 P.M.) with free access to water. Rats were fed a basal diet (Type ME, Oriental Yeast Co., Ltd., Tokyo, Japan). Six rats were given cimetidine (Smith, Kline & French, Philadelphia, PA) as a solution, pH 6.0, containing 100 mg of cimetidine/ml at an intraperitoneal dose of 80 mg/kg twice at 8 A.M. and 8 P.M. for two weeks. The other six rats were given the same volume of the vehicle at the same time for two weeks. Rats were individually caged and given the diet for two weeks. Feces were collected for two days before sacrifice. On the 15th day, cimetidine or the vehicle were injected at 8 A.M. Three hours later, the rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.), and the bile duct was cannulated with PE-10 polyethylene tubing (Clay Adams, Franklin Lakes, NJ) to collect bile for 30 min while maintaining the rectal temperature at 36-37C using an electric warming plate.
Biliary bile acid, cholesterol and phospholipids and fecal bile acids were determined as reported previously (9, 10). Phospholipids were determined by the method of Gomori (11).
Absorption efficiency was calculated as follows (9): 100 X 31 -(daily fecal bile acid excretion/ daily biliary bile acid secretion) I The small and large intestines with their content were homogenized with distilled water and lyophilized. The lyophilized preparations were extracted with 15 ml of ethanol at 90°C for 1 hr three times. The filtrates were combined and evaporated to dryness under reduced pressure. The residue for the large intestine was dissolved in 10 ml of 70% methanol, and neutral lipids were removed by extraction with an equal volume of n-hexane. The 70% methanol layer was evaporated to dryness. The residues were dissolved in 1.25 N NaOH and hydrolyzed at 120°C for 6 hr. After acidification with 2 N HCI, bile acids were extracted with diethyl ether and quantified with GLC.
The pool size of bile acids was obtained by totaling the amounts in the small and large intestines and bile collected for 30 min (10).
The results are expressed as the mean ± S.E.M. Student's t-test was used to determine statistical significance.
Body weight gains were not different between the two groups. Table 1 shows the effect of cimetidine on bile flow, biliary lipid secretion and biliary bile acid composition. Bile flow and biliary secretion of cholesterol, Results are expressed as the mean ± S.E.M. *Statistically significant difference as compared to the control value (P < 0.05).
phospholipids and bile acids remained unaltered by cimetidine treatment. In the biliary bile acid composition, chenodeoxycholic acid increased and 8-muricholic acid decreased significantly in the cimetidine-treated rats as compared with the control rats. With respect to fecal excretion of bile acids and fecal bile acid composition, there was no remarkable difference between the two groups (Table 2 ). However, hyodeoxycholic acid and lithocholic acid tended to increase and a,-muricholic acid tended to decrease by cimetidine treatment; these changes in the fecal bile acids seemed to reflect an increase of chenodeoxycholic acid and a decrease of ,9-muricholic acid in the biliary bile acid composition. There was a slight but significant decrease in the bile acid content of the small intestine by cimetidine treatment, resulting in a reduced pool size of bile acids in the treated rats. Absorption efficiency of the cimetidinetreated rats (95.7 ± 0.7%) was similar to that of the control rats (97.1 ± 0.4%).
Since there was no significant change in absorption efficiency in the rats treated with cimetidine, the effect of cimetidine on splancnic blood flow (1-3) did not seem to be responsible for the reduction of pool size. On the other hand, if cimetidine inhibits cholesterol 7a-hydroxylase, the rate limiting enzyme of bile acid synthesis, as it does cytochrome P-450-mediated drug metabolism (4), bile acid synthesis would decrease, leading to a reduced bile acid pool size. Provided that Results are expressed as the mean ± S.E.M. *Statistically significant difference as compared to the control value (P < 0.05).
fecal excretion of bile acids is in a steady state after two weeks treatment of cimetidine and indicates bile acid synthesis, cimetidine did not seem to alter bile acid synthesis in this study. Further studies are needed to clarify the mechanism of the reduction of the bile acid pool.
In the biliary bile acid composition, chenodeoxycholic acid increased and /3-muricholic acid decreased in the rats treated with cimetidine. Chenodeoxycholic acid is converted to f3-muricholic acid after conversion to amuricholic acid by chenodeoxycholic acid 6l-hydroxylase, a hepatic microsomal cytochrome P-450 (5). Bjorkhem and Danielsson reported that the 6,8-hydroxylase of bile acid resembled microsomal drug hydroxylation in many aspects and thus differed from 7a-hydroxylation of cholesterol and 12a-hydroxylation of 7a-hydroxy-4-cholesten-3-one (12). Considering Bjorkhem's observation together with the fact that cimetidine is a potent inhibitor for the drug hydroxylase (4), the increase of chenodeoxycholic acid with a concomitant decrease of /3-muricholic acid in the biliary bile acid composition seems to result from the inhibition of the 6,3-hydroxylase by cimetidine.
There have been few reports concerning the effect of cimetidine on biliary lipid secretion (6-8). Mok reported that cimetidine therapy did not alter biliary lipid secretion in man (6), while it was reported by Bonazzi et al. that bile flow and biliary secretion of bile acids was not affected, but biliary cholesterol secretion was decreased and biliary phospholipid secretion was increased by intraperitoneal injection of cimetidine in a dose of 120 mg/kg in fed rats (7). Lee demonstrated that intravenous injection of cimetidine (0.5 -4.0 mg/hr/kg) reversed the histamine-induced increase of bile salt-independent bile flow in the sheep (8). In our study, bile flow and biliary lipid secretion were not changed by intraperiotoneal injection of cimetidine at a daily dose of 160 mg/kg for two weeks. These conflicting results might be due to the differences in species.
In conclusion, a high dose of cimetidine could bring about a decrease of the bile acid pool and changes in the biliary bile acid composition in rats.
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